Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial | NeoGenomics Laboratories

Publication date

Fri, 01/03/2025 - 12:00

Category

Multiplex Immunofluorescence

Year

External link

https://www.nature.com/articles/s41591-024-03418-4